Speciality Medicines Ltd. IPO

Speciality Medicines Ltd. is listed in the SME segment. The figures below are as reported by the exchanges and public sources.

Speciality Medicines Ltd. IPO — key facts

• As of 5 September 2026, the Speciality Medicines Ltd. IPO subscription status is 2.27x overall.
• The issue is open from 20-Mar-2026 to 24-Mar-2026.
• Speciality Medicines Ltd. listed on 30-Mar-2026.
• Speciality Medicines Ltd. listed at ₹125.9. The listing gain was 1.5% against the upper end of the issue price band.

Speciality Medicines Ltd. IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price

₹124

Issue size

₹29.14 Cr

Fresh issue

₹27.28 Cr

Opens

20-Mar-2026

Closes

24-Mar-2026

Listing

30-Mar-2026

Total subscription

2.27x

Retail

0.85x

QIB

96.24x

NII

1.88x

Lead managers

Unistone Capital

Listing price

₹125.9

Listing day change

+1.5%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Accretion Nutraveda Ltd. +48.2% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.